Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital made an offer to acquire 10.04% stake in Sinovac Biotech Ltd. for an offer per share of $0.03 on August 24, 2023. As of August 29, 2023, Sinovac?s Board of Directors intends to evaluate the terms of the tender offer to determine the course of action that it believes is in the best interest of the Company and its shareholders. The Board also intends to advise shareholders of the Board?s position regarding the tender offer within ten business days of receipt of the offer.

In the meantime, Sinovac's shareholders are strongly advised to take no action in relation to the tender offer. The offer will expire on September 29, 2023. As of January 8, 2023, the offer will expire on February 21, 2024.